Retinoids

Aging skin & Vitamin A (retinoids)
http://mcb.berkeley.edu

Influence of Retinoids on Embryonic Chick Intestinal Development
J. Orion Rogers and Sheila Shomo
http://www.radford.edu

Vitamin A
https://camcom.ngu.edu

Acne: Evaluation and Management
Betsy Pfeffer MD
http://www.columbia.edu

Vitamins and minerals
http://www.csuchico.edu

Recurrent Respiratory Papillomatosis
Michael E. Decherd, MD, Ronald W. Deskin, MD
http://www2.utmb.edu

The Synthetic Retinoid
Arsen Khachatryan
http://ww2.biol.sc.edu

Fat-Soluble Vitamins
http://35-206-202.wiki.uml.edu

Acne Treatment and Therapeutic Strategies
Dr. Marie Andrades
http://www.pitt.edu

Psoriasis
Mark Gill, PharmD, Professor of Clinical Pharmacy
http://www-hsc.usc.edu

Nuclear Receptors and Cancer
Joe Lipsick
http://www.stanford.edu

462 Published articles on Retinoids

1. Retinoids in the treatment of glioma: a new perspective.
2. Retinoids as Promising Treatment for Non-alcoholic Fatty Liver Disease.
3. Retinoids regulate the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells.
4. Retinoids Reduce Formation of Keratin Aggregates in Heat-stressed Immortalized Keratinocytes from an Epidermolytic Ichthyosis Patient with a KRT10 Mutation*
5. EMBO Retinoids 2011: Mechanisms, biology and pathology of signaling by retinoic acid and retinoic acid receptors.
6. A study on the management of hidradenitis suppurativa with retinoids and surgical excision.
7. Epidermolytic hyperkeratosis: a follow-up of 23 years of use of systemic retinoids.
8. Regulation of keratin expression by retinoids.
9. The thyroid hormone receptors modulate the skin response to retinoids.
10. RIG-I is required for the inhibition of measles virus by retinoids.
11. Design and Synthesis of 3,5-Disubstituted 1,2,4-Oxadiazole Containing Retinoids from a Retinoic Acid Receptor Agonist.
12. Retinoids suppress cysteine-rich protein 61 (CCN1), a negative regulator of collagen homeostasis, in skin equivalent cultures and aged human skin in vivo.
13. Bile retinoids imprint intestinal CD103+ dendritic cells with the ability to generate gut-tropic T cells.
14. Retinoids enhance glucocorticoid-induced apoptosis of T cells by facilitating glucocorticoid receptor-mediated transcription.
15. Allele-specific down-regulation of RPTOR expression induced by retinoids contributes to climate adaptations.
16. p27(Kip1) deficiency promotes prostate carcinogenesis but does not affect the efficacy of retinoids in suppressing the neoplastic process.
17. Endogenous retinoids in mammalian growth plate cartilage: analysis and roles in matrix homeostasis and turnover.
18. Retinoids regulate stem cell differentiation.
19. Systemic retinoids: chemoprevention of skin cancer in transplant recipients.
20. Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations.
21. Effective and sustained delivery of hydrophobic retinoids to photoreceptors.
22. Retinoids for treatment of retinal diseases.
23. Design and Synthesis of Potential New Apoptosis Agents: Hybrid Compounds Containing Perillyl Alcohol and New Constrained Retinoids.
24. Sphingolipidomics of A2780 human ovarian carcinoma cells treated with synthetic retinoids.
25. Retinoids regulate a developmental checkpoint for tissue regeneration in Drosophila.
26. The biochemical and structural basis for trans-to-cis isomerization of retinoids in the chemistry of vision.
27. Relationships among visual cycle retinoids, rhodopsin phosphorylation, and phototransduction in mouse eyes during light and dark adaptation.
28. Signalling with retinoids in the human lung: validation of new tools for the expression study of retinoid receptors.
29. Plasma levels of retinoids, carotenoids and tocopherols in patients with mild obstructive sleep apnoea.
30. Esterase 22 and beta-glucuronidase hydrolyze retinoids in mouse liver.
31. Acidic retinoids synergize with vitamin A to enhance retinol uptake and STRA6, LRAT, and CYP26B1 expression in neonatal lung.
32. Retinoids activate RXR/CAR-mediated pathway and induce CYP3A.
33. Retinoids and proliferative verrucous leukoplakia (PVL). A preliminary study.
34. A possible contribution of retinoids to regulation of fetal B lymphopoiesis.
35. Retinoids inhibit differentiation of hematopoietic osteoclast progenitors.
36. A minute dose of 14C-{beta}-carotene is absorbed and converted to retinoids in humans.
37. Retinoids inhibit measles virus through a type I IFN-dependent bystander effect.
38. Retinoids induce differentiation and downregulate telomerase activity and N-Myc to increase sensitivity to flavonoids for apoptosis in human malignant neuroblastoma SH-SY5Y cells.
39. The role of interphotoreceptor retinoid-binding protein on the translocation of visual retinoids and function of cone photoreceptors.
40. Retinoids synergize with insulin to induce hepatic Gck expression.
41. Detection of endogenous retinoids in the molluscan CNS and characterization of the trophic and tropic actions of 9-cis retinoic acid on isolated neurons.
42. Effect of retinoids on UDP-glucuronosyltransferase 2B7 mRNA expression in Caco-2 cells.
43. Retinoids regulate TGFbeta signaling at the level of Smad2 phosphorylation and nuclear accumulation.
44. Expanding the use of retinoids in acute myeloid leukemia: spotlight on bexarotene.
45. Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation.
46. Retinoids modulate expression of the endocytic partners megalin, cubilin, and disabled-2 and uptake of vitamin D-binding protein in human mammary cells.
47. Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.
48. Selected natural and synthetic retinoids impair CCR7- and CXCR4-dependent cell migration in vitro and in vivo.
49. Retinoids upregulate phosphoenolpyruvate carboxykinase and glyceroneogenesis in human and rodent adipocytes.
50. Upregulation of P2Y2 receptors by retinoids in normal human epidermal keratinocytes.
51. Congenital diaphragmatic hernia and retinoids: searching for an etiology.
52. Retinoids induce cytochrome P450 3A4 through RXR/VDR-mediated pathway.
53. Regulation of FoxP3 regulatory T cells and Th17 cells by retinoids.
54. Retinoids, rexinoids and their cognate nuclear receptors: character and their role in chemoprevention of selected malignant diseases.
55. Retinoids regulate genes involved in retinoic acid synthesis and transport in human myometrial and fibroid smooth muscle cells.
56. Role of the translational repressor 4E-BP1 in the regulation of p21(Waf1/Cip1) expression by retinoids.
57. Improved synthesis of histone deacetylase inhibitors (HDIs) (MS-275 and CI-994) and inhibitory effects of HDIs alone or in combination with RAMBAs or retinoids on growth of human LNCaP prostate cancer cells and tumor xenografts.
58. Retinoids accelerate B lineage lymphoid differentiation.
59. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety.
60. Proliferative changes in the bronchial epithelium of former smokers treated with retinoids.
61. Homing imprinting and immunomodulation in the gut: role of dendritic cells and retinoids.
62. Roles of retinoids and retinoic Acid receptors in the regulation of hematopoietic stem cell self-renewal and differentiation.
63. The chemopreventive effect of retinoids on cellular NF-kappaB activity induced by NMU and NEU in human malignant keratinocytes.
64. Increase of intracellular methylglyoxal levels as a mode of action of retinoids against psoriasis.
65. Retinoids restore normal cyclic nucleotide sensitivity of mutant ion channels associated with cone dystrophy.
66. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
67. Retinoids induce MMP-9 expression through RARalpha during mammary gland remodeling.
68. Retinoids, vitamin D, invasion, and metastasis.
69. MEK blockade converts AML differentiating response to retinoids into extensive apoptosis.
70. Cyclic adenosine monophosphate-dependent cell type-specific modulation of mitogenic signaling by retinoids in normal and neoplastic lung cells.
71. Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents.
72. Retinoids induce growth inhibition and apoptosis in mast cell tumor cell lines.
73. Comparative functional analysis of human medium-chain dehydrogenases, short-chain dehydrogenases/reductases and aldo-keto reductases with retinoids.
74. Apoptosis induction by retinoids in eosinophilic leukemia cells: implication of retinoic acid receptor-alpha signaling in all-trans-retinoic acid hypersensitivity.
75. A comparison of carotenoids, retinoids, and tocopherols in the serum and buccal mucosa of chronic cigarette smokers versus nonsmokers.
76. Bmp2 and Gata4 function additively to rescue heart tube development in the absence of retinoids.
77. Isolation of ribonuclease P activity from human epidermis and its regulation by retinoids in vitro.
78. Retinoids activate the RXR/SXR-mediated pathway and induce the endogenous CYP3A4 activity in Huh7 human hepatoma cells.
79. Retinoids during the in vitro transition from bovine morula to blastocyst.
80. Clinical trials with retinoids for breast cancer chemoprevention.
81. Retinoids and spermatogenesis: lessons from mutant mice lacking the plasma retinol binding protein.
82. Retinoids have differing efficacies on alveolar regeneration in a dexamethasone-treated mouse.
83. Retinoids signal directly to zebrafish endoderm to specify insulin-expressing beta-cells.
84. Involvement of serum retinoids and Leiden mutation in patients with esophageal, gastric, liver, pancreatic, and colorectal cancers in Hungary.
85. Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers.
86. Receptor-related mechanism of proliferation inhibilion and apoptosis induetion of human tongue squamous cell line Tca8113 by retinoids.
87. Physiological and receptor-selective retinoids modulate interferon gamma signaling by increasing the expression, nuclear localization, and functional activity of interferon regulatory factor-1.
88. High concentrations of retinoids induce differentiation and late apoptosis in pancreatic cancer cells in vitro.
89. Positively charged retinoids are potent and selective inhibitors of the trans-cis isomerization in the retinoid (visual) cycle.
90. Retinoids and retinol differentially regulate steroid biosynthesis in ovarian theca cells isolated from normal cycling women and women with polycystic ovary syndrome.
91. Natural retinoids inhibit proliferation and induce apoptosis in pancreatic cancer cells previously reported to be retinoid resistant.
92. Biochemical properties of purified human retinol dehydrogenase 12 (RDH12): catalytic efficiency toward retinoids and C9 aldehydes and effects of cellular retinol-binding protein type I (CRBPI) and cellular retinaldehyde-binding protein (CRALBP) on the oxidation and reduction of retinoids.
93. A conserved retinoid X receptor (RXR) from the mollusk Biomphalaria glabrata transactivates transcription in the presence of retinoids.
94. Concentrations of retinoids in early pregnancy and in newborns and their mothers.
95. Activation of p53, inhibition of telomerase activity and induction of estrogen receptor beta are associated with the anti-growth effects of combination of ovarian hormones and retinoids in immortalized human mammary epithelial cells.
96. The potential immunomodulatory effects of topical retinoids.
97. Retinoids potentiate peroxisome proliferator-activated receptor gamma action in differentiation, gene expression, and lipid metabolic processes in developing myeloid cells.
98. The effect of doxorubicin and retinoids on proliferation, necrosis and apoptosis in MCF-7 breast cancer cells.
99. Retinoids and pulmonary hypertension.
100. Upregulation of CD44 and hyaluronate synthases by topical retinoids in mouse skin.
101. Retinoids: inducers of tumor/growth suppressors.
102. Retinoids arrest breast cancer cell proliferation: retinoic acid selectively reduces the duration of receptor tyrosine kinase signaling.
103. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?.
104. Retinoic acid increases the expression of p53 and proapoptotic caspases and sensitizes keratinocytes to apoptosis: a possible explanation for tumor preventive action of retinoids.
105. Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways.
106. Phosphodiesterase IV inhibition by piclamilast potentiates the cytodifferentiating action of retinoids in myeloid leukemia cells. Cross-talk between the cAMP and the retinoic acid signaling pathways.
107. Retinoids and cancer: antitumor effect of ATRA and of a new derivative of retinoic acid, IIF, on colon carcinoma cell lines CaCo-2 and HT-29.
108. Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1.
109. Modifying effects of 1'-acetoxychavicol acetate (ACA) and the novel synthetic retinoids Re-80, Am-580 and Am-55P in a two-stage carcinogenesis model in female rats.
110. The specificity of alcohol dehydrogenase with cis-retinoids. Activity with 11-cis-retinol and localization in retina.
111. The proteosome inhibitor MG132 attenuates retinoic acid receptor trans-activation and enhances trans-repression of nuclear factor kappaB. Potential relevance to chemo-preventive interventions with retinoids.
112. Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells.
113. Retinoids assist the cellular folding of the autosomal dominant retinitis pigmentosa opsin mutant P23H.
114. Alpha-tocopherol and ascorbic acid decrease the production of beta-apo-carotenals and increase the formation of retinoids from beta-carotene in the lung tissues of cigarette smoke-exposed ferrets in vitro.
115. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids.
116. Analysis of retinoids and carotenoids: problems resolved and unsolved.
117. Oxidative conversion of carotenoids to retinoids and other products.
118. Retinoids and drugs of abuse: implications for neurological disease risk in human immunodeficiency virus type 1 infection.
119. Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytes.
120. Transcription suppression of thromboxane receptor gene expression by retinoids in vascular smooth muscle cells.
121. The transcription factor NGFI-B (Nur77) and retinoids play a critical role in acute neuroleptic-induced extrapyramidal effect and striatal neuropeptide gene expression.
122. Functional specificity of two hormone response elements present on the human apoA-II promoter that bind retinoid X receptor alpha/thyroid receptor beta heterodimers for retinoids and thyroids: synergistic interactions between thyroid receptor beta and upstream stimulatory factor 2a.
123. Retinoids regulate survival and antigen presentation by immature dendritic cells.
124. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
125. The role of vitamin D and retinoids in controlling prostate cancer progression.
126. An International Evaluation of the Cancer-Preventive Potential of Nine Retinoids.
127. A novel role for retinoids in patterning the avian forebrain during presomite stages.
128. Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats.
129. Acute radiolabeling of retinoids in eye tissues of normal and rpe65-deficient mice.
130. Differential regulation of nonsteroidal anti-inflammatory drug-activated gene in normal human tracheobronchial epithelial and lung carcinoma cells by retinoids.
131. Regulation of the cardiac mitochondrial membrane potential by retinoids.
132. Retinoids, alveolus formation, and alveolar deficiency: clinical implications.
133. Synergism between nuclear receptors bound to specific hormone response elements of the hepatic control region-1 and the proximal apolipoprotein C-II promoter mediate apolipoprotein C-II gene regulation by bile acids and retinoids.
134. Retinoids and alcohol-related carcinogenesis.
135. Vitamin A (retinoids) regulation of mouse melanoma growth and differentiation.
136. Pharmacological doses of some synthetic retinoids can modulate both the aryl hydrocarbon receptor and retinoid receptor pathways.
137. Retinoids regulate the anterior expression boundaries of 5' Hoxb genes in posterior hindbrain.
138. Caspase-14 expression by epidermal keratinocytes is regulated by retinoids in a differentiation-associated manner.
139. Absence of retinoids can induce motoneuron disease in the adult rat and a retinoid defect is present in motoneuron disease patients.
140. Retinoids induce lumen morphogenesis in mammary epithelial cells.
141. Bis-indols: a novel class of molecules enhancing the cytodifferentiating properties of retinoids in myeloid leukemia cells.
142. Nuclear (receptor) power: retinoids in rat mesangioproliferative disease.
143. The role of retinoids and retinoic acid receptors in normal hematopoiesis.
144. Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line.
145. The effect of retinoids on premalignant oral lesions: focus on topical therapy.
146. Deficits in the posterior pharyngeal endoderm in the absence of retinoids.
147. Retinoic acid receptors and retinoids are up-regulated in the developing and adult rat prostate by neonatal estrogen exposure.
148. Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/Bax.
149. Transcriptional induction of mitogen-activated protein kinase phosphatase 1 by retinoids. Selective roles of nuclear receptors and contribution to the antiapoptotic effect.
150. Retinoids and lung cancer: targeting the right population.
151. All-trans-retinal shuts down rod cyclic nucleotide-gated ion channels: a novel role for photoreceptor retinoids in the response to bright light?
152. Selective alteration of gene expression in response to natural and synthetic retinoids.
153. Human choriocarcinoma cell line JEG-3 produces and secretes active retinoids from retinol.
154. Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms.
155. Activation of c-Raf kinase by ultraviolet light. Regulation by retinoids.
156. Classical and novel retinoids: their targets in cancer therapy.
157. Retinoids, cisplatin and interferon-alpha in recurrent or metastatic cervical squamous cell carcinoma: clinical results of 2 phase II trials.
158. Effect of natural and synthetic retinoids on the proliferation and differentiation of three canine melanoma cell lines.
159. Increased antibody production by retinoids is related to the fusion partner of human hybridomas.
160. Midkine is involved in kidney development and in its regulation by retinoids.
161. Unique property of some synthetic retinoids: activation of the aryl hydrocarbon receptor pathway.
162. Lung cancer prevention: retinoids and the epidermal growth factor receptor-a phoenix rising?
163. Retinoids suppress epidermal growth factor-associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1/2 activation.
164. Alveolar proliferation, retinoid synthesizing enzymes, and endogenous retinoids in the postnatal mouse lung. Different roles for Aldh-1 and Raldh-2.
165. Effects of retinoids on the TGF-beta system and extracellular matrix in experimental glomerulonephritis.
166. Isomerization of 11-cis-retinoids to all-trans-retinoids in vitro and in vivo.
167. Where to next with retinoids for cancer therapy?
168. Evidence for indirect control of phospholipase C (PLC-beta) by retinoids in Drosophila phototransduction.
169. Induction of cell cycle arrest and morphological differentiation by Nurr1 and retinoids in dopamine MN9D cells.
170. Possible role of retinoids in hepatitis B virus-associated liver damage.
171. Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells.
172. Expression and characterization of a murine enzyme able to cleave beta-carotene. The formation of retinoids.
173. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation.
174. Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators.
175. Retinoids: new insight into smooth muscle cell growth inhibition.
176. In vitro inhibition of proliferation of estrogen-dependent and estrogen-independent human breast cancer cells treated with carotenoids or retinoids.
177. Characterization of a novel airway epithelial cell-specific short chain alcohol dehydrogenase/reductase gene whose expression is up-regulated by retinoids and is involved in the metabolism of retinol.
178. Effects of receptor-selective retinoids on CYP26 gene expression and metabolism of all-trans-retinoic acid in intestinal cells.
179. Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma.
180. Retinoids for ovarian cancer prevention: laboratory data set the stage for thoughtful clinical trials.
181. Up-regulation of steroid sulphatase activity in HL60 promyelocytic cells by retinoids and 1alpha,25-dihydroxyvitamin D3.
182. Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells.
183. A vertebrate aldo-keto reductase active with retinoids and ethanol.
184. Potential role of retinoids in the therapy of renal disease.
185. Retinoids induce fibroblast growth factor-2 production in endothelial cells via retinoic acid receptor alpha activation and stimulate angiogenesis in vitro and in vivo.
186. Regulation of mouse kappa opioid receptor gene expression by retinoids.
187. Effect of retinoids on growth inhibition of two canine melanoma cell lines.
188. Modulation of the synaptic Ca2+ current in salamander photoreceptors by polyunsaturated fatty acids and retinoids.
189. Retinoids as ligands and coactivators of protein kinase C alpha.
190. The retinoids and cancer prevention mechanisms.
191. Is there a role for retinoids to treat minimal residual disease in neuroblastoma?
192. Regulation of CYP26 (cytochrome P450RAI) mRNA expression and retinoic acid metabolism by retinoids and dietary vitamin A in liver of mice and rats.
193. Retinoids: versatile biological response modifiers of vascular smooth muscle phenotype.
194. Retinoic acid regulation of Cdx1: an indirect mechanism for retinoids and vertebral specification.
195. Retinoids and arterial smooth muscle cells.
196. beta-carotene is converted primarily to retinoids in rats in vivo.
197. Transcriptional activation of the human ucp1 gene in a rodent cell line. Synergism of retinoids, isoproterenol, and thiazolidinedione is mediated by a multipartite response element.
198. TCDD suppression of tissue transglutaminase stimulation by retinoids in malignant human keratinocytes.
199. Retinoids stimulate leptin synthesis and secretion in human syncytiotrophoblast.
200. Retinoids in embryonal development.
201. Retinoids in chemoprevention and differentiation therapy.
202. Critical role of the H6-H7 loop in the conformational adaptation of all-trans retinoic acid and synthetic retinoids within the ligand-binding site of RARalpha.
203. Retinoids and demethylating agents- looking for partners.
204. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
205. Multiple effects of retinoids on the development of Sertoli, germ, and Leydig cells of fetal and neonatal rat testis in culture.
206. The effect of lipid environment and retinoids on the ATPase activity of ABCR, the photoreceptor ABC transporter responsible for Stargardt macular dystrophy.
207. Evidence that retinoic acid receptor beta induction by retinoids is important for tumor cell growth inhibition.
208. The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer.
209. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.
210. Advances in the development of retinoids as chemopreventive agents.
211. SN-1, a novel leukemic cell line with t(11;16)(q23;p13): myeloid characteristics and resistance to retinoids and vitamin D3.
212. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
213. Morphogenetic action of retinoids and estrogens.
214. Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids.
215. Both retinoic-acid-receptor- and retinoid-X-receptor-dependent signalling pathways mediate the induction of the brown-adipose-tissue-uncoupling-protein-1 gene by retinoids.
216. Retinoids activate proton transport by the uncoupling proteins UCP1 and UCP2.
217. Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids.
218. Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-alpha and retinoids.
219. Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids.
220. F-actin as a functional target for retro-retinoids: a potential role in anhydroretinol-triggered cell death.
221. Retinoids: present role and future potential.
222. Morphological clues from multilegged frogs: are retinoids to blame?
223. Action of retinoids on embryonic and early postnatal testis development.
224. Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB.
225. Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci.
226. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
227. Ligand-dependent activation of transcription in vitro by retinoic acid receptor alpha/retinoid X receptor alpha heterodimers that mimics transactivation by retinoids in vivo.
228. Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoids.
229. Retinoids are produced by glia in the lateral ganglionic eminence and regulate striatal neuron differentiation.
230. Activity of human 11-cis-retinol dehydrogenase (Rdh5) with steroids and retinoids and expression of its mRNA in extra-ocular human tissue.
231. Apoptosis induction of POS canine osteosarcoma cells by vitamin D and retinoids.
232. Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression.
233. Retinoic acid receptor alpha mediates growth inhibition by retinoids in rat pancreatic carcinoma DSL-6A/C1 cells.
234. Overexpressed activated retinoid X receptors can mediate growth inhibitory effects of retinoids in human carcinoma cells.
235. Acute promyelocytic leukemia, histone deacetylase, and response to retinoids.
236. Inhibition of ribonuclease P activity by retinoids.
237. Regulation by retinoids of P2Y2 nucleotide receptor mRNA in human uterine cervical cells.
238. Segment-specific pattern of sympathetic preganglionic projections in the chicken embryo spinal cord is altered by retinoids.
239. Retinoids are endogenous to the porcine blastocyst and secreted by trophectoderm cells at functionally-active levels.
240. Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.
241. Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression.
242. Three independent lines of evidence suggest retinoids as causal to schizophrenia.
243. Retinoids modulate P2U purinergic receptor-mediated changes in transcervical paracellular permeability.
244. Expression of retinoic acid receptor-beta sensitizes prostate cancer cells to growth inhibition mediated by combinations of retinoids and a 19-nor hexafluoride vitamin D3 analog.
245. Characterization of a region upstream of exon I.1 of the human CYP19 (aromatase) gene that mediates regulation by retinoids in human choriocarcinoma cells.
246. Retinoids and their receptors in vertebrate embryogenesis.
247. Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy.
248. Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family.
249. Analysis of esterification of retinoids in the retinal pigmented epithelium of the Mitf-vit (vitiligo) mutant mouse.
250. Retinoids regulate tight junctional resistance of cultured human cervical cells.
251. Prevention by retinoids of azoxymethane-induced tumors and aberrant crypt foci and their modulation of cell proliferation in the colon of rats.
252. Retinoids and alcoholic liver disease.
253. Mechanism of the slow induction of apolipoprotein A-I synthesis by retinoids in cynomolgus hepatocytes: involvement of retinoic acid and retinoid X receptors.
254. Regulation of the mouse cellular retinoic acid-binding protein-I gene by thyroid hormone and retinoids in transgenic mouse embryos and P19 cells.
255. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
256. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
257. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.
258. Measurement of retinoids and carotenoids in breast adipose tissue and a comparison of concentrations in breast cancer cases and control subjects.
259. Anticoagulant effects of synthetic retinoids mediated via different receptors on human leukemia and umbilical vein endothelial cells.
260. Activation of the orphan receptor RIP14 by retinoids.
261. Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells.
262. Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro.
263. Positional apoptosis during vertebrate CNS development in the absence of endogenous retinoids.
264. Glucuronidation of retinoids by rat recombinant UDP: glucuronosyltransferase 1.1 (bilirubin UGT).
265. Retinoid antagonism of NF-IL6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma.
266. Roles of retinoids and their nuclear receptors in the development and prevention of upper aerodigestive tract cancers.
267. Induction of apoptosis by retinoids and retinoic acid receptor gamma-selective compounds in mouse thymocytes through a novel apoptosis pathway.
268. Stromelysin-3 induction and interstitial collagenase repression by retinoic acid. Therapeutical implication of receptor-selective retinoids dissociating transactivation and AP-1-mediated transrepression.
269. Modulation of interferon action by retinoids. Induction of murine STAT1 gene expression by retinoic acid.
270. Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2.
271. On the mechanism of isomerization of ocular retinoids by the crayfish Procambarus clarkii.
272. Lecithin:retinol acyltransferase and retinyl ester hydrolase activities are differentially regulated by retinoids and have distinct distributions between hepatocyte and nonparenchymal cell fractions of rat liver.
273. Suprabasal expression of a dominant-negative RXR alpha mutant in transgenic mouse epidermis impairs regulation of gene transcription and basal keratinocyte proliferation by RAR-selective retinoids.
274. Conformational analysis of retinoids and restriction of their dynamics by retinoid-binding proteins.
275. Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes.
276. Raloxifene, retinoids, and lavender: "me too" tamoxifen alternatives under study.
277. RXRalpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids.
278. Treatment of axolotls with retinoids for limb regeneration studies.
279. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
280. Retro-retinoids in regulated cell growth and death.
281. Retinoids in lung development.
282. Vitamin A and retinoids in antiviral responses.
283. Retinoids and Hox genes.
284. A history of vitamin A and retinoids.
285. High-performance liquid chromatography-electrospray mass spectrometry of retinoids.
286. Retinoids in cancer chemoprevention.
287. Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor.
288. All-trans-retinoic acid 4-hydroxylation in human liver microsomes: in vitro modulation by therapeutic retinoids.
289. Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells.
290. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
291. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
292. Potential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferons.
293. Cloning and regulation of cornifin beta, a new member of the cornifin/spr family. Suppression by retinoic acid receptor-selective retinoids.
294. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element.
295. Receptor-selective retinoids implicate retinoic acid receptor alpha and gamma in the regulation of bmp-2 and bmp-4 in F9 embryonal carcinoma cells.
296. Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells.
297. Endogenous retinoids in the zebrafish embryo and adult.
298. Enhancement of HL-60 differentiation by a new class of retinoids with selective activity on retinoid X receptor.
299. Measurement of carotenoids, retinoids, and tocopherols in human lenses.
300. Retinoids stimulate fibrinogen production both in vitro (hepatocytes) and in vivo. Induction requires activation of the retinoid X receptor.
301. Relation between beta-carotene intake and plasma and adipose tissue concentrations of carotenoids and retinoids.
302. Efficient inhibition of activation-induced Fas ligand up-regulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors.
303. Visceral heterotaxy syndrome induced by retinoids in mouse embryo.
304. Regulation of the induction of ornithine decarboxylase in keratinocytes by retinoids.
305. Retinoids downregulate both p60 and p80 forms of tumor necrosis factor receptors in human histiocytic lymphoma U-937 cells.
306. Interactions with retinol and retinoids of bovine cellular retinol-binding protein.
307. Evidence for the involvement of retinoic acid receptor RAR alpha-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids.
308. Endogenous distribution of retinoids during normal development and teratogenesis in the mouse embryo.
309. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha-interferon in inhibition of cervical carcinoma cell proliferation.
310. Modulations of elastin expression and cell proliferation by retinoids in cultured vascular smooth muscle cells.
311. Retinoids (all-trans and 9-cis retinoic acid) stimulate production of macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor by human bone marrow stromal cells.
312. Inhibition of nitric oxide synthesis in vascular smooth muscle by retinoids.
313. Crystallographic studies on complexes between retinoids and plasma retinol-binding protein.
314. Retinoids suppress proliferation, induce cell spreading, and up-regulate connexin43 expression only in postconfluent 10T1/2 cells: implications for the role of gap junctional communication.
315. Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids.
316. Correspondence re: S.E. Dew et al., Effects of pharmacological retinoids on several vitamin A-metabolizing enzymes. Cancer Res., 53: 2965-2969, 1993.
317. Retinoids and vertebrate development.
318. Modulation of collagen synthesis and degradation by retinoids and cytokines in 3T3 L1 preadipocytes.
319. Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP).
320. Suppression of squamous cell carcinoma growth and differentiation by retinoids.
321. Recombinant human retinoic acid receptor beta. Binding of synthetic retinoids and transcriptional activation.
322. Carotenoids, tocopherols, and retinoids in human buccal mucosal cells: intra- and interindividual variability and storage stability.
323. Retinoids regulate gonadotropin action in cultured rat Sertoli cells.
324. Retinoids, breast cancer and NK cells.
325. Unfolding of newly made retinol-binding protein by dithiothreitol. Sensitivity to retinoids.
326. Retinoids stimulate ApoA-I synthesis by induction of gene transcription in primary hepatocyte cultures from cynomolgus monkey (Macaca fascicularis)
327. Retinoids: in vitro interaction with retinol-binding protein and influence on plasma retinol.
328. Effects of pharmacological retinoids on several vitamin A-metabolizing enzymes.
329. Retinoids increase urokinase-type plasminogen activator production by human retinal pigment epithelial cells in culture.
330. The interactions of retinoids with retinol-binding protein. A resonance Raman spectroscopic study.
331. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers.
332. A nonsaponification method for the determination of carotenoids, retinoids, and tocopherols in solid human tissues.
333. In vivo biological activity of retinoids partially correlates to their affinity to recombinant retinoic-acid receptor alpha and recombinant-cellular retinoic-acid-binding protein I.
334. Cellular metabolism and activation of retinoids: roles of cellular retinoid-binding proteins.
335. Endogenous retinoids in rat epididymal tissue and rat and human spermatozoa.
336. An everted repeat mediates retinoic acid induction of the gamma F-crystallin gene: evidence of a direct role for retinoids in lens development.
337. Cellular retinoic-acid-binding-protein and retinol-binding-protein mRNA expression in the cells of the rat seminiferous tubules and their regulation by retinoids.
338. Effects of retinoids on tooth morphogenesis and cytodifferentiations, in vitro.
339. Cornifin, a cross-linked envelope precursor in keratinocytes that is down-regulated by retinoids.
340. Comparative teratogenicity of nine retinoids in the rat.
341. Retinoids, retinoid-responsive genes, cell differentiation, and cancer.
342. The role of arrestin and retinoids in the regeneration pathway of rhodopsin.
343. Retinoids are important cofactors in T cell activation.
344. Simultaneous liquid chromatographic determination of carotenoids, retinoids, and tocopherols in human buccal mucosal cells.
345. Interactions between retinoids and TGF beta s in mouse morphogenesis.
346. Developmental changes in endogenous retinoids during pregnancy and embryogenesis in the mouse.
347. Developmental regulation of Sertoli cell aromatase activity and plasminogen activator production by hormones, retinoids and the testicular paracrine factor, PModS.
348. Recombinant human retinoic acid receptor alpha. Binding of DNA and synthetic retinoids to the protein expressed in Escherichia coli.
349. Effect of retinoids on nuclear retinoic acid receptors mRNA in adipose tissue of retinol-deficient rats.
350. Retinoids and retinoid-binding protein expression in rat adipocytes.
351. Retinoids and carotenoids in the prevention of oral cancer: a critical appraisal.
352. Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoids.
353. The role of retinoids in normal and abnormal embryonic craniofacial morphogenesis.
354. Topical and oral retinoids protect Langerhans' cells and epidermal Thy-1+ dendritic cells from being depleted by ultraviolet radiation.
355. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia.
356. Identification of retinoids with nuclear receptor subtype-selective activities.
357. Structure-activity relationships of retinoids as inhibitors of calmodulin-dependent human erythrocyte Ca(2+)-ATPase activity and calmodulin binding to membranes.
358. Metabolism of natural retinoids in psoriatic epidermis.
359. Multi-stage program of differentiation in human epidermal keratinocytes: regulation by retinoids.
360. Effect of retinoids on the release and gene expression of tumor necrosis factor-alpha in human peripheral blood monocytes.
361. Immortalization of human keratinocytes by simian virus 40 large T-antigen alters keratin gene response to retinoids.
362. Retinoids and butyrate modulate fibroblast growth and contraction of collagen matrices.
363. Synthesis of retinoids by human retinal epithelium and transfer to rod outer segments.
364. Oral retinoids.
365. Regulation of type I (epidermal) transglutaminase mRNA levels during squamous differentiation: down regulation by retinoids.
366. Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids.
367. Visual toxicity of synthetic retinoids.
368. Modulation of 3-methylcholanthrene toxicity in cultured neoplastic keratinocytes by glucocorticoids and retinoids is not accounted for by macromolecular adduct formation.
369. The actions of retinoids on cellular growth correlate with their actions on gap junctional communication.
370. Effect of substratum and retinoids upon the mucosecretory differentiation of airway epithelial cells in vitro.
371. The effect of retinoids on dendritic cell function.
372. Enhancement of the expression of activation markers on human peripheral blood mononuclear cells by in vitro culture with retinoids and carotenoids.
373. Inhibition by retinoids of platelet growth factor-dependent stimulation of DNA synthesis and cell division in density-arrested C3H 10T1/2 fibroblasts.
374. Inhibition of Moloney murine lymphoma and sarcoma growth in vivo by dietary retinoids.
375. Comparative aspects of carotenoids and retinoids as chemopreventive agents for cancer.
376. Effects of retinoids on macrophage function and IL-1 activity.
377. Differential effects of retinoids and chronic ethanol consumption on membranes in rats.
378. Effects of dietary retinoids upon growth and differentiation of tumors derived from several murine embryonal carcinoma cell lines.
379. Effect of retinoids on xenotransplanted human mammary carcinoma cells in athymic mice.
380. Influence of retinoids on growth and metastasis of hamster melanoma in athymic mice.
381. Distributions of retinoids, retinoid-binding proteins and related parameters in different types of liver cells isolated from young and old rats.
382. Inhibition by retinoids of anthralin-induced mouse epidermal ornithine decarboxylase activity and anthralin-promoted skin tumor formation.
383. Regulation of human mesothelial cell differentiation: opposing roles of retinoids and epidermal growth factor in the expression of intermediate filament proteins.
384. Comparative activity of dietary or topical exposure to three retinoids in the promotion of skin tumor induction in mice.
385. Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts.
386. Recent advances in clinical use of retinoids.
387. Effects of retinoids on metabolizing enzymes and on binding of benzo(a)pyrene to rat tissue DNA.
388. Subcellular localization of retinoids, retinoid-binding proteins, and acyl-CoA:retinol acyltransferase in rat liver.
389. Retinoids reprogramme pre-bud mesenchyme to give changes in limb pattern.
390. Cell surface dynamics of neutrophils stimulated with phorbol esters or retinoids.
391. Retinoids as important regulators of terminal differentiation: examining keratin expression in individual epidermal cells at various stages of keratinization.
392. Regulation of accessory cell function by retinoids in murine immune responses.
393. Studies on the in vivo transfer of retinoids from parenchymal to stellate cells in rat liver.
394. In-vitro teratogenicity of retinoids.
395. Isomerization of all-trans-retinoids to 11-cis-retinoids in vitro.
396. Induction of tissue transglutaminase in human peripheral blood monocytes by intracellular delivery of retinoids.
397. Inhibition of conjunctival transdifferentiation by topical retinoids.
398. Detection of radical species in mixtures of some retinoids with hematin by using the ESR spin-trapping technique.
399. Synthesis of mucous glycoproteins by rabbit tracheal cells in vitro. Modulation by substratum, retinoids and cyclic AMP.
400. Characterization of transglutaminase activity in rabbit tracheal epithelial cells. Regulation by retinoids.
401. Accumulation of cholesterol 3-sulfate during in vitro squamous differentiation of rabbit tracheal epithelial cells and its regulation by retinoids.
402. Retinoic acid-binding protein in the chick limb bud: identification at developmental stages and binding affinities of various retinoids.
403. Retinoids. Structure-function relationship in normal and leukemic hematopoiesis in vitro.
404. Correlation between the induction of leukemic cell differentiation by various retinoids and modulation of protein kinases.
405. The effects of two retinoids on limb regeneration in Pleurodeles waltl and Triturus vulgaris.
406. Hepatic retinol metabolism. Distribution of retinoids, enzymes, and binding proteins in isolated rat liver cells.
407. Retinoids, retinoid-binding proteins, and retinyl palmitate hydrolase distributions in different types of rat liver cells.
408. Effect of retinoids on the growth, ultrastructure, and cytoskeletal structures of malignant rat osteoblasts.
409. Computer-assisted correlation of structure and biological activity in a set of retinoids.
410. Metabolism of retinoids by embryonal carcinoma cells.
411. Human T-cell leukemia virus I induction by 5-iodo-2'-deoxyuridine and N-methyl-N'-nitro-N-nitrosoguanidine: inhibition by retinoids, L-ascorbic acid, and DL-alpha-tocopherol.
412. Synthetic retinoids in dermatology.
413. Modulation of procollagen gene expression by retinoids. Inhibition of collagen production by retinoic acid accompanied by reduced type I procollagen messenger ribonucleic acid levels in human skin fibroblast cultures.
414. Comparative study of blocking effects of various retinoids on the occurrence of permanent proliferation of vaginal epithelium in mice treated neonatally with estrogen.
415. Retinoids and pattern formation in a hydroid.
416. Retinoid feeding, hormone inhibition, and/or immune stimulation and the progression of N-methyl-N-nitrosourea-induced rat mammary carcinoma: suppression by retinoids of peptide hormone-induced tumor cell proliferation in vivo and in vitro.
417. Relationship between binding affinities to cellular retinoic acid-binding protein and biological potency of a new series of retinoids.
418. Regulation of epidermal transglutaminase activity and terminal differentiation by retinoids and phorbol esters.
419. Induction of ornithine decarboxylase activity and DNA synthesis in hairless mouse epidermis by retinoids.
420. Effects of four retinoids in N-nitrosobis(2-oxopropyl)amine-treated hamsters.
421. Divergent effects of retinoids on pancreatic and liver carcinogenesis in azaserine-treated rats.
422. Role of retinoids in differentiation and carcinogenesis.
423. Retinoids induce differentiation of type A spermatogonia in vitro: organ culture of mouse cryptorchid testes.
424. Inhibition of carcinogenesis by retinoids.
425. Action of epidermal growth factor and retinoids on anchorage-dependent and -independent growth of nontransformed rat kidney cells.
426. Action of retinoids on the anchorage-independent growth of normal rat kidney fibroblasts induced by 12-O-tetradecanoylphorbol-13-acetate or sarcoma growth factor.
427. Nomenclature of retinoids. Recommendations 1981.
428. Utilization of retinoids in the bullfrog retina.
429. Variable effects of retinoids on two pigmenting human melanoma cell lines.
430. Identification of the endogenous retinoids associated with three cellular retinoid-binding proteins from bovine retina and retinal pigment epithelium.
431. Retinoids and phorbol esters alter release of fibronectin from enucleated cells.
432. Secretion of testicular transferrin by cultured Sertoli cells is regulated by hormones and retinoids.
433. Retinoids increase transglutaminase activity and inhibit ornithine decarboxylase activity in Chinese hamster ovary cells and in melanoma cells stimulated to differentiate.
434. Inhibition of pancreatic carcinogenesis by retinoids in azaserine-treated rats.
435. Photochemical destruction of the virucidal activities of retinoids and unsaturated fatty acids.
436. Retinoids in experimental diets.
437. Effects of retinoids and phorbol esters on the sensitivity of different cell lines to the polypeptide toxins modeccin, abrin, ricin and diphtheria toxin.
438. N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids.
439. Modification of sister chromatid exchanges and radiation-induced transformation in rodent cells by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate and two retinoids.
440. Anti-cancer action of retinoids.
441. Dermatology-epitomes of progress: update on the use of retinoids.
442. Effects of retinoids on normal and neoplastic human cells cultured in vitro.
443. Structure-activity relationships of retinoids in hamster tracheal organ culture.
444. Structure-activity relationships among various retinoids and their ability to inhibit neoplastic transformation and to increase cell adhesion in the C3H/10T1/2 CL8 cell line.
445. Stimulation of melanogenesis in a human melanoma cell line by retinoids.
446. Retinoids as regulators of macrophage function.
447. Characterization of the effects of different retinoids on the growth and differentiation of a human melanoma cell line and selected subclones.
448. Mechanism of virucidal activity of retinoids: protein removal from bacteriophage phi 6 envelope.
449. Inhibition of carcinogenesis by retinoids.
450. Binding of retinoids to human breast cancer cell lines and their effects on cell growth.
451. Effects of retinoids on induction of differentiation of cultured mouse myeloid leukemia cells.
452. Relationship between binding affinities to cellular retinoic acid-binding protein and in vivo and in vitro properties for 18 retinoids.
453. Inhibition of human melanoma colony formation by retinoids.
454. Reversible inhibition by retinoids of 3-methylcholanthrene-induced neoplastic transformation in C3H/10T1/2 clone 8 cells.
455. Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion.
456. Assay of retinoids in biological samples by reverse-phase high-pressure liquid chromatography.
457. Determination of binding affinities of retinoids to retinoic acid-binding protein and serum albumin.
458. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis by vitamin A analogs (retinoids).
459. Separation of the natural retinoids by high-pressure liquid chromatography.
460. Chemical synthesis of phosphorylated retinoids. Their mannosyl acceptor activity in rat liver membranes.
461. Toxicity of anti-carcinogenic retinoids in organ culture.
462. Effect of aromatic retinoids on rat chondrosarcoma glycosaminoglycan biosynthesis.